Viewing SEC Facts Units
Company Name:
Enlivex Therapeutics Ltd.
CIK:
1596812
Start Filing Date:
2020-04-01
End Filing Date:
2020-06-30
ACCN:
0001213900-20-030994
Value:
$ 13,441,436
Value Error:
$ None
Created By:
Date Filed:
2020-10-13
FY:
2020
Fiscal Period:
Q2
Frame:
CY2019Q2
Type:
us-gaap
Form:
6-K/A
Units:
shares